Skip to main content
. 2018 Jun 14;8(2):130–139. doi: 10.1159/000489505

Fig. 3.

Fig. 3

Relationship between overall survival hazard ratio (OS HR) and time to progression (TTP) HR among the trials in which tumor progression was assessed by TTP (a) and progression-free survival (PFS) (b). Each trial is represented by a circle, with its size proportional to the number of patients. TTP HR and PFS HR were consistently correlated with OS HR (R = 0.72 and R = 0.70, respectively) on the basis of weighted linear regression (*).